Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
2 More than four billion people - about 50% of the worlds population - are estimated to be impacted by obesity or will be overweight by 2035
A few caveats are worth noting about these eligibility criteria You could qualify for the Bridge program even though your BMI falls short of the figures cited above if you already are taking a GLP-1 and your BMI was high enough to qualify immediately before your use of that weight-loss drug began
First, federal health plans have already started covering these medications
Tirzepatide is the only dual GLP-1/GIP agonist on this list of GLP-1 medications, and the most potent currently approved
Field Crops Res 2002;77:93-8
